|
2009~2011年武汉地区β-内酰胺类复方制剂利用情况调查 |
Analysis of Application of β-lactam Compound Preparation in 32 Hospitals in Wuhan |
投稿时间:2012-06-20 修订日期:2012-07-19 |
DOI: |
中文关键词: β-内酰胺类复方制剂 用药频度 日均费用 药物利用 |
英文关键词:β-lactam compound preparation Frequency of drug use Average daily costs Drug utilization |
基金项目: |
|
摘要点击次数: 1047 |
全文下载次数: 1163 |
中文摘要: |
摘 要 目的:了解武汉地区β-内酰胺类复方制剂使用情况,为合理用药提供依据。方法:对武汉地区32家医院2009~2011年β-内酰胺类复方制剂使用数量、消耗金额、用药频度(DDDs)和日均费用(DDC)进行统计分析。结果:2009~2011年头孢菌素类复方制剂销售额呈增长趋势,年增幅平均在34%以上,而青霉素类复方制剂多呈下降趋势,但阿莫西林/克拉维酸3 年中用药频度始终居于首位。结论:随着抗菌药耐药情况日益严重,β-内酰胺类复方制剂抗菌药使用的合理性和经济学指标有待深入评价。 |
英文摘要: |
ABSTRACT Objective:To investigate the application of β-lactam compound preparation to provide the evidence for rational use of medicines.Methods:The number and cost, frequency of drug use ( DDDs) and average daily costs ( DDC) of β-lactam compound preparation consumed in 32 hospitals in Wuhan from 2009-2011 were statistically analyzed.Results:During the 3 years, cephalosporin compound showed a rising trend, and the average annual growth rate was more than 34% while the compound of penicillin showed a downward trend. Amoxicillin / clavulanic acid DDDs always took the first place. Conclusion:With the growing antibiotics resistance, their rational use and drug economics of β-lactam compound preparation need further evaluation. |
查看全文 查看/发表评论 下载PDF阅读器 |
关闭 |